Literature DB >> 31437695

Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study.

Mu-Hong Chen1, Wei-Chen Lin1, Pei-Chi Tu2, Cheng-Ta Li1, Ya-Mei Bai1, Shih-Jen Tsai1, Tung-Ping Su3.   

Abstract

BACKGROUND: Increasing evidence suggests that infusion of a subanesthetic dose of ketamine exerts antidepressant and antisuicidal effects in patients with treatment-resistant depression (TRD). AIMS: In this investigation, we used the resting functional connectivity magnetic resonance imaging (fcMRI) to determine the effects of ketamine on the functional connectivity (FC) of prefrontal cortex (PFC)-related circuits in patients with TRD.
METHODS: Forty-eight patients with TRD were recruited and randomly divided into three groups on the basis of ketamine infusion dose: 0.5 mg/kg (standard dose), 0.2 mg/kg (low dose), or normal saline (a placebo infusion). Resting functional MRI data and clinical data were recorded at the baseline and on the third day after ketamine infusion treatment.
RESULTS: The standard-dose group showed a reduction in the FC of the left dorsal anterior cingulate cortex (dACC) and right dorsolateral (dl)PFC with the other frontal regions. The low-dose group demonstrated a more pervasive reduction of FC in the bilateral dACC with other frontal and parietal regions. A negative correlation was observed between the reduction in suicidal ideation and the reduction in the FC between the left dACC and right ACC regions in the standard-dose group, whereas a positive correlation was observed between the reduction in suicidal ideation and the increase in the FC between the right dlPFC and left superior parietal region in the low-dose group.
CONCLUSIONS: Our results support the hypothesis that PFC-related circuit modulation is crucial to the antidepressant and antisuicidal effects of the ketamine infusion treatment.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Anterior cingulate cortex; Functional connectivity; Ketamine; Prefrontal cortex; Suicide; Treatment-resistant depression

Mesh:

Substances:

Year:  2019        PMID: 31437695     DOI: 10.1016/j.jad.2019.08.022

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  18 in total

Review 1.  The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders.

Authors:  Gerard Sanacora; Zhen Yan; Maurizio Popoli
Journal:  Nat Rev Neurosci       Date:  2021-12-10       Impact factor: 34.870

Review 2.  Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.

Authors:  Rebecca L Dean; Claudia Hurducas; Keith Hawton; Styliani Spyridi; Philip J Cowen; Sarah Hollingsworth; Tahnee Marquardt; Annabelle Barnes; Rebecca Smith; Rupert McShane; Erick H Turner; Andrea Cipriani
Journal:  Cochrane Database Syst Rev       Date:  2021-09-12

Review 3.  Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review.

Authors:  Ilya Demchenko; Vanessa K Tassone; Sidney H Kennedy; Katharine Dunlop; Venkat Bhat
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

4.  Transient effects of multi-infusion ketamine augmentation on treatment-resistant depressive symptoms in patients with treatment-resistant bipolar depression - An open-label three-week pilot study.

Authors:  Chuanjun Zhuo; Feng Ji; Hongjun Tian; Lina Wang; Feng Jia; Deguo Jiang; Ce Chen; Chunhua Zhou; Xiaodong Lin; Jingjing Zhu
Journal:  Brain Behav       Date:  2020-07-03       Impact factor: 2.708

Review 5.  Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.

Authors:  Samuel Kohtala
Journal:  Pharmacol Rep       Date:  2021-02-20       Impact factor: 3.024

Review 6.  Prefrontal cortex and depression.

Authors:  Diego A Pizzagalli; Angela C Roberts
Journal:  Neuropsychopharmacology       Date:  2021-08-02       Impact factor: 7.853

Review 7.  Biomarkers of ketamine's antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology.

Authors:  Alexandra A Alario; Mark J Niciu
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-05-31

8.  Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives.

Authors:  Cheolmin Shin; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2020-03-23       Impact factor: 2.505

9.  Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.

Authors:  Shiau-Shian Huang; Hsi-Han Chen; Jui Wang; Wei J Chen; Hsi-Chung Chen; Po-Hsiu Kuo
Journal:  BMC Psychiatry       Date:  2020-11-17       Impact factor: 3.630

Review 10.  Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials.

Authors:  Dongjiao An; Changwei Wei; Jing Wang; Anshi Wu
Journal:  Front Psychol       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.